The VAs are at the heart of an ongoing dispute with brokers and broker-dealers over canceled trail commissions.
MBS exchange-traded fund is seeing demand from investors looking for safety and a little more yield.
Rising interest rates and a volatile stock market pushed 2018 sales to a record, including all-time-high indexed annuity sales.
CEO Robert Moore's resignation signals further adjustments at the IBD network.
Investor advocate calls insurance proposal weaker than existing broker suitability standard
Bulk of the outflow occurred at Allianz unit Pimco.
His struggle to attract assets shows how low fees and passive investing have brought star managers back down to earth.
Advisers wonder what the lack of a formal brokerage agreement means from a regulatory standpoint.
Sources say Kestra is being valued at between $600 million and $800 million, about eight to 10 times EBITDA.
Fixed indexed annuities are an insured asset class unto themselves.
But a memorable stock ticker can give exchange-traded funds a boost.
IBD agrees to repay customers $1.9 million in addition to a $225,000 fine
Bigger cash weightings reveal a preference for safety over returns as the bull market ages
Readers are flocking to stories on tax-free munis — but why?
It's all about convergence, and those who leverage it will reap the rewards
Both will now offer more than 500 exchange-traded funds on a commission-free basis.
ETF fees have fallen, but so far no providers have matched Fidelity's offer of free mutual funds
Investors need an active money manager for one simple reason: to protect them from themselves
Insurer partners with DPL Financial's insurance network to distribute annuity products through independent RIAs.
Discussions ended in December because the parties couldn't agree on a price.
